There are more than 60 different peptide combinations approved for medical use around the world, with 150 more in the clinical research phases
In many autoimmune diseases, including Hashimotos, there is an imbalance between these branches
Other clinical insights Russian doctors flagged: - Selank + Semax is common for cognitive use, but can worsen anxiety in already-anxious individuals (Semax is stimulating) - Injectable BPC-157 has much stronger neurotransmitter effects than the oral capsule - Capsule BPC-157 is preferred for gut-only applications (IBS, inflammatory bowel issues) - In cautious protocols, bioregulator peptides should precede BPC-157 There's a wide gap between how peptides are marketed in the West and how they're used in Russian clinical practice
An FDA panel recently voted against the NDA of Qnexa because of safety concerns (Table 3 )
When supplied as lyophilised powder, BPC-157 exists in a dehydrated crystalline state
Elsewhere, the FDA warns that the use of these experimental drugs, like BPC 157, GHK, and GHRP-6, in compounded medicationmeaning medication that is tailored by a pharmacist to an individuals special needsposes a risk for immune reactions